Website:
Cepheid
Group: Danaher
Catalog excerpts
Viral Load Monitoring for Quality of Life. Xpert® HIV-1 Viral Load Flexibility for personalised care. Putting the patient first. In Vitro Diagnostic Medical Device C€ m A better way.
Open the catalog to page 1
Xpert® HIV-1 Viral Load delivers excellent performance as required for routine patient follow-up with the advantages of being simple and flexible enough to accommodate any daily test volume as well as any urgent single analysis.” Prof. Jean-Christophe Plantier Head of the Virology laboratory, laboratory associated to the HIV French National Reference Center Rouen University Hospital, Rouen, France The World Health Organization estimates that 35 million Xpert HIV-1 Viral Load is a quantitative test that provides people worldwide are currently living with HIV/AIDS.1 on-demand molecular...
Open the catalog to page 2
THE IMPACT • Improve Patient Care: Same day results support better clinical decisions • Increase Efficiency: Rapid results enable earlier adjustments to appropriate therapy • Strengthen Communities: Quick decisions can help reduce drug resistance Move your lab forward • No Waiting: Deliver individual patient results when they’re most needed • Simple & Organised: True 24/7 random access accommodates other urgent test requests • Flexible: Adapt to any throughput requirement • Improve Service: Run more than one test simultaneously PERFORMANCE A multi site study across Europe and the USA was...
Open the catalog to page 3
Total hands-on time: <1 minute System Throughput 8-hr shift Transfer at least 1 mL of plasma into the cartridge * Operational throughput per 8-hr shift based on HIV-1 Viral Load testing, internal analysis. Scan, load cartridge and start test Xpert® HIV-1 Viral Load provides individual on-demand viral load measurements in real time for HIV-1. Xpert HIV-1 Viral Load CATALOG INFORMATION References: 1. WHO. HIV/AIDS Fact sheet N°360. Updated November 2014. 2. Katzenstein DA, et all. The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected...
Open the catalog to page 4All Cepheid catalogs and technical brochures
-
Xpert® Xpress Flu/RSV4 Pages
-
GeneXpert® Infinity Systems8 Pages
-
The New GeneXpert®12 Pages
-
Cepheid Virology Brochure4 Pages
-
Xpert® Breast Cancer STRAT44 Pages
-
Xpert® HIV-1 Qual4 Pages
-
Xpert® HCV Viral Load4 Pages
-
Xpert® FII & FV4 Pages
-
Xpert® HBV Viral Load4 Pages
-
Xpert® HPV4 Pages
-
Xpert® TV4 Pages
-
Xpert® MTB/RIF Ultra4 Pages
-
Xpert® Xpress Strep A4 Pages
-
Xpert® Xpress Flu/RSV4 Pages
-
Xpert® Norovirus4 Pages
-
GeneXpert® System12 Pages
-
Xpert® BCR-ABL Ultra4 Pages
-
Xpert® CT/NG6 Pages
-
Xpert® MRSA/SA BC4 Pages
-
Xpert® vanA/vanB4 Pages
-
Xpert® Carba-R4 Pages
-
Xpert® Ebola4 Pages
-
Xpert® MRSA NxG4 Pages
-
Xpert® C. difficile BT4 Pages
-
Cepheid Corporate Overview16 Pages
-
Xpert® MTB/RIF4 Pages
-
Xpert® GBS3 Pages
-
Xpert® EV3 Pages
-
Xpert® MRSA/SA SSTI4 Pages
-
Xpert® SA Nasal Complete4 Pages
-
Xpert® MRSA2 Pages
